PRDM2 and breast cancer: Finally, the methylation of ADAM23, CCNA1, CCND2, CDH1, CDH13, CDKN1C, ESR1, PRDM2, SFN, SLIT2, TNFRSF10C, and TP73 did not show any significant associations with OS rate in BC patients.